Artificial Intelligence
SJS/TEN Treatment Market to Observe Highest Growth of USD 12,586.71 Million with an Excellent CAGR of 7.6% by 2030
HOUSTON, May 31, 2023 (GLOBE NEWSWIRE) — The newest report from Data Bridge Market Research, “SJS/TEN Treatment Market” examines growth strategies, drivers, opportunities, key segments, Porter’s Five Forces analysis, and the competitive environment in detail. SJS/TEN Treatment market research document help business or organization in every sphere of trade to take better decisions, to respond the toughest business questions, and reduce the risk of failure. It gives details about market drivers and market restraints which can help businesses in guessing about reducing or increasing the production of a particular product. A strong research methodology used here consists of data models that include a market overview and guide, vendor positioning grid, market timeline analysis, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis, and vendor share analysis. Market share analysis and key trend analysis are the two other major success factors in SJS/TEN Treatment market report.
The leading SJS/TEN Treatment business report provides the supreme base for competitor analysis, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market and SJS/TEN Treatment industry. This is a professional and meticulous report, which focuses on primary and secondary drivers, market share, leading segments, and geographical analysis. The report also helps to know about the types of consumers, their response and views about particular products, and their thoughts on the step-up of a product. The most appropriate method for the distribution of certain products can also be analyzed with SJS/TEN Treatment market research study.
The global SJS/TEN treatment market is expected to gain market growth in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.6% in the forecast period of 2023 to 2030 and is expected to reach USD 12,586.71 million by 2030 from USD 7,100.00 million in 2022.
Get a Sample PDF of the SJS/TEN Treatment Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-sjs-ten-treatment-market
The treatment market for Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) is relatively small due to the rarity of these diseases.
The SJS/TEN treatment market is dominated by drugs, as drugs are the main form of treatment for these conditions. Corticosteroids, intravenous immunoglobulin (IVIG), and antibiotics are the most commonly used medications in the treatment of SJS/TEN.
The global SJS/TEN treatment market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an analyst brief. Our team will help you create a revenue-impact solution to achieve your desired goal. The scalability and business expansion of the retail units in the developing countries of various regions and partnership with suppliers for safe distribution of machine and drug products are the major drivers which propelled the demand of the market in the forecast period.
The Latest Study Conducts a Comprehensive Analysis of the Global Market, considering the current competitive landscape and its future evolution in the next few years.
The global SJS/TEN Treatment market is experiencing rapid growth, fueled by rising demands, industrialization, consumer awareness, and technological advancements. Sales and revenue in this sector have surged at an exponential pace, and the market’s expansion is expected to continue over the projected period.
In order to expand their market share and reach a wider client base, leading businesses in the worldwide SJS/TEN Treatment market are heavily investing in research and development. The study provides detailed insights into the strategies, financial health, revenue, gross margin, and growth rates of these companies.
Opportunity:
- Developing Effective and Safe Treatment for SJS/TEN
Stem cell transplantation is a new approach that aims to replace damaged skin and mucous membranes with healthy tissue. Autologous stem cell transplantation, where stem cells are taken from the patient’s skin and grown in culture before being transplanted back into the damaged area, has shown promising results in small studies.
Recent Developments:
- In June 2020, BD, a leading global medical technology company announced that they have completed the acquisition of Straub Medical AG, a privately-held company. With this acquisition, the company has added the valuable expertise and experience of Straub Medical AG and expanded its product portfolio. This will help the company to expand and grow in the market.
- In January 2019, Mölnlycke Health Care AB. acquires MandJ Airlaid Products A/S to further strengthen its wound care capabilities. In connection with the acquisition, MandJ, and its employees will be an integral part of Mölnlycke. The acquisition will improve Mölnlycke’s security of supply for the air-laid material needed to produce advanced wound dressings and help grow the wound care business by accelerating innovation and product development in existing and future products. This will help the company to expand and grow in the market.
The most prominent players in the SJS/TEN Treatment market include.
- Cardinal Health (U.S.)
- Smith + Nephew (U.K.)
- Novartis AG (Switzerland)
- Amneal Pharmaceuticals LLC. (U.S.)
- Amgen Inc. (U.S.)
- Pfizer Inc. (U.S.)
- Colgate-Palmolive Company (U.S.)
- Merck & Co., Inc. (U.S.)
- Mölnlycke Health Care AB. (Sweden)
- Xttrium Laboratories (U.S.)
- Schülke & Mayr GmbH (Germany)
- ICPA Health Products Ltd (India)
- Purdue Pharma L.P. (U.S.)
- Eugia (Subsidiary of Aurobindo Pharma)
- AdvaCare PharmaTop of Form
Click Here to Download the Complete Research Study in PDF Format @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-sjs-ten-treatment-market
Our market intelligence platform provides a range of benefits that will help you gain valuable insights and stay ahead in the market. By utilizing our platform, you can:
- Identify emerging market trends and dynamics
- Access high-quality and accurate market intelligence
- Benchmark your performance against competitors and industry standards
- Explore competitive strategies and analyze market share
- Discover regional market opportunities that may have been overlooked
- Choose from multiple deliverable formats, including PDF, PPT, Excel, and an online dashboard
With our comprehensive market intelligence platform, you can easily access the information you need to make informed decisions and stay ahead of the competition.
At Data Bridge Market Research, we employ a comprehensive and iterative research methodology aimed at minimizing deviations to provide the most accurate estimates and forecasts possible. Our approach involves utilizing both bottom-up and top-down methods to segment and estimate the quantitative aspects of the market. Furthermore, a recurring theme across all our research reports is data triangulation, which examines the market from three distinct perspectives.
To derive our market estimates and forecasts, we employ simulation models that are tailored for each study. We gather information on market dynamics, technology landscape, application development, and pricing trends, which are then fed into the model and analyzed simultaneously. We compare these factors and quantify their impact on the forecast period using correlation, regression, and time series analysis. Our market forecasting is performed using a combination of economic tools, technological analysis, and our team’s industry experience and domain expertise.
Key Market Segments Covered in SJS/TEN Treatment Industry Research
Treatment
- Medications
- Support Care
- Hospitalization
Diagnosis
- Physical Exam
- Medical History
- Skin Biopsy
Cause
- Specific Treatment
Route of Administration
- Parenteral
Drug Type
Therapy Type
- Monotherapy
- Combination Therapy
Patient Type
End User
- Specialty Clinics
- Ambulatory Surgical Center
- Homecare Setting
Distribution Channel
- Direct Tenders
- Retail Pharmacies
Explore Further Details about This Research Report @ https://www.databridgemarketresearch.com/reports/global-sjs-ten-treatment-market
Key Industry Drivers:
- Increasing Prevalence and Incidence of SJS/TEN
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are serious and potentially life-threatening conditions involving the skin and mucous membranes. SJS and TEN are considered two ends of the disease spectrum, with SJS being the milder form and TEN being the more severe form. A characteristic feature of these conditions is the separation of the epidermis (the outer layer of the skin) from the dermis (the layer below the skin) due to a strong immune reaction.
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but serious skin diseases characterized by the separation of the epidermis from the dermis. The incidence of SJS/TEN has been reported to be around 1 per million people per year. However, in recent years there has been increased concern about the incidence and prevalence of SJS/TEN.
- Advances in Drug Development for SJS/TEN Treatment
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are serious and potentially life-threatening conditions that require prompt and aggressive treatment. Although there is currently no specific medication or treatment that can cure SJS/TEN, advances in drug development have led to better treatment strategies and treatment outcomes for affected patients. But there are various clinical trials going on for drug development for SJS/TEN treatment.
SJS/TEN Treatment Market Regional Analysis/Insights:
The countries covered in this SJS/TEN Treatment Market Report U.S., Canada, Mexico, Germany, U.K., France, Italy, Russia, Spain, Netherlands, Denmark, Switzerland, Sweden, Poland, Norway, Finland, Belgium, Turkey, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Indonesia, Philippines, Thailand, Malaysia, Singapore, Vietnam, Taiwan, Rest of Asia-Pacific, Saudi Arabia, South Africa, Bahrain, Kuwait, Oman, Qatar, U.A.E., Egypt, Israel, and Rest of Middle East and Africa, Brazil, Argentina, Rest of South America.
Asia-Pacific is expected to dominate the global SJS/TEN treatment market. China dominates in the Asia-Pacific region due to the presence of key market players in the largest consumer market with high GDP.
Core Objective of SJS/TEN Treatment Market:
Every firm in the SJS/TEN Treatment market has objectives but this market research report focus on the crucial objectives, so you can analyze about competition, future market, new products, and informative data that can raise your sales volume exponentially.
- SJS/TEN Treatment Market Size and growth rate factors.
- Important changes in the future SJS/TEN Treatment Market.
- Top worldwide competitors of the Market.
- Scope and product outlook of SJS/TEN Treatment Market.
- Developing regions with potential growth in the future.
- Tough Challenges and risk faced in the Market.
- Global SJS/TEN Treatment top manufacturers profile and sales statistics
Table of Contents:
- Introduction
- Market Segmentation
- Executive Summary
- Premium Insights
- Global SJS/TEN Treatment Market: Regulations
- Market Overview
- Global SJS/TEN Treatment Market, By Treatment
- Global SJS/TEN Treatment Market, By Diagnosis
- Global SJS/TEN Treatment Market, By Cause
- Global SJS/TEN Treatment Market, By Route of Administration
- Global SJS/TEN Treatment Market, By Drug Type
- Global SJS/TEN Treatment Market, By Therapy Type
- Global SJS/TEN Treatment Market, By Patient Type
- Global SJS/TEN Treatment Market, By End User
- Global SJS/TEN Treatment Market, By Distribution Channel
- Global SJS/TEN Treatment Market, By Region
- Global SJS/TEN Treatment Market: Company Landscape
- SWOT Analyses
- Company Profile
- Questionnaires
- Related Reports
Download the Complete Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-sjs-ten-treatment-market
Explore More Reports:
- Europe SJS/TEN Treatment Market, By Treatment (Medications, Support care, Hospitalization, Isolation, Ointments and Others), Diagnosis (Physical Exam, Skin Biopsy, Medical History, Blood Test, Cultures and Others), Cause (Specific Treatment, Infection and Others), Route of Administration (Oral, Parenteral, Topical and Others), Drug Type (Branded and Generic), Therapy Area (Combination Therapy and Monotherapy), Patient Type (Geriatric, Adult and Pediatric), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Center, Homecare Setting and Others), Distribution Channel (Retail Pharmacies, Direct Tender and Others) – Industry Trends and Forecast to 2030 https://www.databridgemarketresearch.com/reports/europe-sjs-ten-treatment-market
- Asia-Pacific SJS/TEN Treatment Market, By Treatment (Medications, Support care, Hospitalization, Isolation, Ointments and Others), Diagnosis (Physical Exam, Skin Biopsy, Medical History, Blood Test, Cultures and Others), Cause (Specific Treatment, Infection and Others), Route of Administration (Oral, Parenteral, Topical and Others), Drug Type (Branded and Generic), Therapy Area (Combination Therapy and Monotherapy), Patient Type (Geriatric, Adult and Pediatric), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Center, Homecare Setting and Others), Distribution Channel (Retail Pharmacies, Direct Tender and Others) – Industry Trends and Forecast to 2030 https://www.databridgemarketresearch.com/reports/asia-pacific-sjs-ten-treatment-market
- Middle East and Africa SJS/TEN Treatment Market, By Treatment (Medications, Support care, Hospitalization, Isolation, Ointments and Others), Diagnosis (Physical Exam, Skin Biopsy, Medical History, Blood Test, Cultures and Others), Cause (Specific Treatment, Infection and Others), Route of Administration (Oral, Parenteral, Topical and Others), Drug Type (Branded and Generic), Therapy Area (Combination Therapy and Monotherapy), Patient Type (Geriatric, Adult and Pediatric), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Center, Homecare Setting and Others), Distribution Channel (Retail Pharmacies, Direct Tender and Others) – Industry Trends and Forecast to 2030 https://www.databridgemarketresearch.com/reports/middle-east-and-africa-sjs-ten-treatment-market
- North America SJS/TEN Treatment Market, By Treatment (Medications, Support care, Hospitalization, Isolation, Ointments and Others), Diagnosis (Physical Exam, Skin Biopsy, Medical History, Blood Test, Cultures and Others), Cause (Specific Treatment, Infection and Others), Route of Administration (Oral, Parenteral, Topical and Others), Drug Type (Branded and Generic), Therapy Area (Combination Therapy and Monotherapy), Patient Type (Geriatric, Adult and Pediatric), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Center, Homecare Setting and Others), Distribution Channel (Retail Pharmacies, Direct Tender and Others) – Industry Trends and Forecast to 2030 https://www.databridgemarketresearch.com/reports/north-america-sjs-ten-treatment-market
- Cycloplegic Agents Market, By Mechanism of Action (Atropine, Cyclopentolate, Cyclomidril, Phenylephrine), Root (Oral, Topical), Indication (Amblyopic Therapy, Palliative Care for Phthisis, Uveitis), Distribution Channel (Hospital, Online, Retail) https://www.databridgemarketresearch.com/reports/global-cycloplegic-agents-market
- Non-Opioid Pain Treatment Market, By Products (Medical Cannabis, Menthol- Containing, Omega 3 Fatty Acid Containing, Botulinum Toxins, Capsaicin Derived), Therapeutic Applications (Orthopaedic and Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Other Pain), Drug Type (Acetaminophen, Non-steroidal Anti-inflammatory Drugs, Corticosteroids, Anticonvulsants, Serotoninnorepinephrine Reuptake Inhibitor Antidepressants), Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies) – Industry Trends and Forecast to 2029 https://www.databridgemarketresearch.com/reports/global-non-opioid-pain-treatment-market
- Bone Marrow-Derived Stem Cells (BMSCS) Market, By Service Type (Sample Preservation and Storage, Sample Analysis, Sample Processing, Sample Collection and Transportation), Application (Personalized Banking Applications, Research Applications, Clinical Applications) – Industry Trends and Forecast to 2029 https://www.databridgemarketresearch.com/reports/global-bone-marrow-derived-stem-cells-bmscs-market
- Anti-Acne Mask Market, By Product Type (Organic, Artificial), Source (Natural, Synthetic), Population (Women, Men), Mask Type (Clay Mask, Natural Ingredient, Peel Off Mask, Sheet Mask, Cream Mask, Warm Oil Mask), Packaging Type (Tubes, Sachets, Container/Jars), Distribution Channel (Online, Offline, Specialty Stores, Supermarket and Hypermarket, Drug Stores, Beauty Salons) https://www.databridgemarketresearch.com/reports/global-anti-acne-mask-market
- Female Neonatal Devices Market, By Type (Bone Densitometry, Breast Biopsy, Breast Imaging, Monitoring Device, Infant Warmer and Incubator, Gynecological Chair, Other), Application (Female, Neonatal) https://www.databridgemarketresearch.com/reports/global-female-neonatal-devices-market
- Magnetic Resonance Imaging (MRI) Pulse Oximeters Market, By Type (Wired MRI Pulse oximeters, Wireless MRI Pulse oximeters), Modality (Sensor with monitor, Sensor without monitor), End- User (Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers), Product (Fingertip Pulse Oximeters, Hand- Held Pulse Oximeters, Others) https://www.databridgemarketresearch.com/reports/global-mri-pulse-oximeters-market
- Biomarker Translation Services Market, By Product (Reagents, Instruments), Functional Genomics (Transfection, Real-time PCR, RNA Interference, Mutational Analysis, SNP Analysis, Microarray Analysis), Pathway Analysis (Bead-based Analysis, Microarray Analysis, Proteomics Tools), Biomarker Discovery (Mass Spectrometry, Real-time PCR, Microarray Analysis, Statistical Analysis, Bioinformatics, DNA Sequencing, Others), End Use (Clinical Research, Government and Academic Institutes, Biotechnology and Pharmaceutical Companies, Hospitals and Clinics, and Others) https://www.databridgemarketresearch.com/reports/global-biomarker-translation-services-market
- Cord Blood and Cell Banking Market, By Type of Bank (Public, Private), Services (Processing, Storage), Application (Cancer, Blood Disorders, Immuno-deficiency Disorders, Metabolic Disorders, Bone Marrow Failure Syndrome), End-Use (Hospitals, Research Institutes, Specialty Clinics) https://www.databridgemarketresearch.com/reports/global-cord-blood-and-cell-banking-market
- Netherlands Wet Age-Related Macular Degeneration (AMD) Market, By Drug Class (Monoclonal Antibodies, Benzoporphyrin Derivative, Others), Product (Biologics, Biosimilar), Age Group (60–80 Years, Above 80 Years, 40–59 Years), Disease Type (Wet AMD, Dry AMD), Stages (Early AMD, Intermediate AMD, Advanced AMD, No AMD), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) https://www.databridgemarketresearch.com/reports/netherlands-wet-age-related-macular-degeneration-amd-market
About Data Bridge Market Research:
An absolute way to forecast what the future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- [email protected]
Artificial Intelligence
Rainbow Robotics begins pre-orders of Bimanual Mobile Manipulator RB-Y1, the world’s first research platform for AI experts for $80,000 USD
DAEJEON, South Korea, May 9, 2024 /PRNewswire/ — Rainbow Robotics(CEO Jungho Lee), a robot platform specialized company, will begin pre-orders for the Bimanual Mobile Manipulator RB-Y1 from May 8.
During the pre-order period, the research platform is sold for $80,000 USD and the commercial platform is sold for $120,000 USD (VAT excluded). Products are scheduled to be delivered sequentially starting in October.
RB-Y1 is a research platform that has both arms with 7 degrees of freedom per arm for smooth movements similar to human movements. It is a humanoid-like robot with a single leg with 6 degrees of freedom on a mobile platform for a wide work radius. The LiDAR system is adopted for autonomous movement, and a high-performance 3D recognition sensor and master ARM are provided as options to increase usability. In line with the recent trend of the AI era, Rainbow Robotics plans to provide various APIs and options so that AI developers can easily utilize them for research purposes.
Recently, various organizations are introducing humanoid robots. However, they are only used for their own purposes and there is no standard platform for various AI robot researchers. Rainbow Robotics’ RB-Y1 is the first to commercially sell such a research platform.
Unlike existing simple industrial robots, a Bimanual Mobile Manipulator is a humanoid robot that uses both arms and is suitable for advanced manufacturing sites and services. It is a next-generation robot platform that can be used for complex assembly, manufacturing, and collaboration beyond existing simple automation processes.
If you would like to pre-order RB-Y1, please contact us through enquiry page or email us at [email protected].
Meanwhile, Rainbow Robotics will participate as a bronze sponsor in the IEEE International Conference on Robotics and Automation (ICRA 2024), which will be held at Pacifico Yokohama, Japan on May 13.
During the exhibition, various demonstrations will be shown of controlling RB-Y1 with real-time remote operation technology, which links the data arm and simulation system. Additionally, Rainbow Robotics plans to exhibit the small, high-precision collaborative robot RB3-730 and the quadruped robot RBQ-10.
Photo – https://mma.prnewswire.com/media/2407480/Caption___Rainbow_Robotics_Press_Release__Rainbow_Robotics_begins_pre_orders_of_Bimanual_Mobile_Mani.jpg
View original content:https://www.prnewswire.co.uk/news-releases/rainbow-robotics-begins-pre-orders-of-bimanual-mobile-manipulator-rb-y1–the-worlds-first-research-platform-for-ai-experts-for-80-000-usd-302139719.html
Artificial Intelligence
AgriBusiness Global™ Announces 2024 Event Line-Up: Connecting Crop Input Leaders Worldwide
WILLOUGHBY, Ohio, May 8, 2024 /PRNewswire/ — AgriBusiness Global, the premier business source for leaders in the global crop input value chain, is thrilled to announce its lineup of events for 2024. For 37 years, AgriBusiness Global has been the go-to resource for quality, trustworthy information and analysis, leading the industry in providing the next generation of crop solutions covering synthetic crop protection, biologicals, and plant health.
In 2024, AgriBusiness Global will host three events, each designed to connect industry leaders, promote innovation, and drive business growth:
AgriBusiness Global℠ LATAM Conference Date: 14-15 MayLocation: Panama City, Panama
Capitalizing on Emerging Technologies in LATAM
The ABG LATAM Conference will bring together industry experts and influencers to discuss the latest trends and developments in crop protection, plant health, biologicals, and ag technology specific to the Latin American region. The Latin-American market offers new opportunities for business growth and partnerships with leading players in the region. Learn More>
AgriBusiness Global℠ Trade Summit Date: 7-8 AugustLocation: Orlando, Florida, USA
The #1 Global Agribusiness Event- Dedicated to Worldwide Networking and New Business Development
The ABG Trade Summit is the trusted forum for advancing development in the rapidly emerging global crop protection, ag tech, plant health, and biological sectors. Attendees can expect to meet with the world’s leading manufacturers, exporters, trading companies, sellers, formulators, and consultants. Trade Summit facilitates global trade by offering educational sessions, a robust exhibit floor, private meeting rooms, and dedicated networking opportunities for the world market to connect, engage, and build business. Learn More>
AgriBusiness Global℠ SE Asia ConferenceDate: 6-7 NovemberLocation: Jakarta, Indonesia
Empowering Southeast Asia’s AgriBusiness for Global Impact
The ABG Southeast Asia Conference, produced in cooperation with the Indonesian CropCare Association, will showcase cutting-edge technologies and innovations in crop production, addressing the unique challenges and opportunities in the Southeast Asian market. Attendees will gain unique insights to prepare for the future and navigate the present in the rapidly evolving agricultural market. Learn More>
“Our events are dynamic platforms for industry leaders to connect, collaborate, and drive innovation,” said Eric Davis, Group Director at AgriBusiness Global. “We are excited to bring together the brightest minds in the industry to explore new ideas, foster partnerships, and shape the future of agriculture.”
For information about the 2024 events and how to participate, visit AgriBusinessGlobal.com.
About Meister Media Worldwide
For media inquiries, please contact:Amy Reddington, Show Director
Logo – https://mma.prnewswire.com/media/2080421/4694823/Meister_Media_Worldwide_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/agribusiness-global-announces-2024-event-line-up-connecting-crop-input-leaders-worldwide-302140221.html
Artificial Intelligence
Economic Shifts Ahead as AI Integrates Deeply into Work and Society, Fueling $4.4 Trillion Growth
USA News Group News Commentary
Issued on behalf of Scope AI Corp.
VANCOUVER, May 8, 2024 /PRNewswire/ — USA News Group News Commentary – New developments in AI technology are currently changing the face of work, economies, and society as we know it, according to analysts at McKinsey & Company who are projecting generative AI (gen AI) could add $4.4 trillion annually to the global economy. Between January and March of this year alone, the world’s largest cloud-computing giants have collectively invested $40 billion mostly into data centres equipped to deal with growing AI workloads, according to The Economist. The shift is leading experts to witness how AI companies are leading a transition from Software-as-a-Service to Service-as-Software, turning the table on the very essence of SaaS, representing a $4.6 trillion opportunity. A variety of tech companies have recently advanced the integration of AI, providing swift, safe, and cost-effective solutions for businesses to adopt artificial intelligence technology this past week, including: Scope AI Corp. (CSE: SCPE) (OTCQB: SCPCF), Meta Platforms, Inc. (NASDAQ: META), Amazon.com, Inc. (NASDAQ: AMZN), Apple Inc. (NASDAQ: AAPL), and C3.ai, Inc. (NYSE: AI).
The article continued: Seeing the extraordinary speed of AI’s advancements and impacts, combined with surging private- and public-sector demand, is causing regulators in the USA and EU to issue legislation calling for action. Now analysts are trying to determine whether the GenAI boom is setting up to be another bubble, or a legitimate long-term investment opportunity.
SCOPE AI PROVIDES CORPORATE UPDATE
Scope AI Corp. (CSE: SCPE) (OTCQB: SCPCF) (FSE: VN8) (“Scope” or the “Company”) today provided an update on new developments of Scope’s artificial intelligence driven recognition technology called GEM (General Enterprise Machine Learning) system. Built on advanced visual recognition and neural network technology, GEM could advance industries, including Advertising and Gaming, by providing them with new insights and capabilities.
Advertising: GEM aims to enable advertising businesses to personalize ad content based on real-time user behavior analysis. By leveraging visual recognition technology, companies can create highly targeted and engaging ads, maximizing return on ad spend and driving customer engagement to new heights.
Gaming: In the gaming industry, GEM aims to enhance user experiences by customizing gameplay and recommendations. By analyzing player behavior using neural networks, GEM provides customers and developers with invaluable insights with the intention of optimizing game design, increasing user retention, and maximizing revenue potential.
Unveiling Neural Networks: Neural networks are the foundation of GEM’s technology. These complex algorithms mimic the structure and functionality of the human brain, enabling machines to learn from vast amounts of data and make intelligent predictions and decisions. By harnessing the power of neural networks, GEM offers comprehensive capabilities in advanced pattern recognition, data analysis, and decision-making across industries.
“We’re very pleased at how seamless we were able to streamline, enhance, and strengthen our platform with the latest performance and security upgrades made to our infrastructure”, said Sean Prescott, Founder and Non-Executive Chairman of Scope AI. “The next generation of our platform will set us apart in the kind and sensitivity of data we can process and store. It’s a potential game-changer for the industry.”
Scope’s GEM platform includes advanced features designed to enhance user experience and security, all while streamlining operations. Built-in customer support and user management modules allow for seamless assistance, while the native referral system fosters user engagement and growth. Along with the full admin suite for comprehensive analysis and reporting, businesses are fully empowered with unparalleled capabilities and insights.
CONTINUED… Read this and more news for Scope AI at: https://usanewsgroup.com/2024/04/26/the-currency-of-tomorrow-why-investing-in-cutting-edge-ai-recognition-tech-could-mean-big-money/
In other industry developments and happenings in the market this week include:
Meta Platforms, Inc. (NASDAQ: META), the parent company of Facebook, Instagram, and WhatsApp, recently teamed up with the Georgia Institute of Technology to create a massive open dataset to advance AI solutions for carbon capture, a technology with promising potential to address global climate concerns. As per the collaboration, Georgia Tech and Meta say their massive database could potentially make it easier and faster to design and implement new direct air capture technologies.
“The open-source database enabled the team to train an AI model that is orders of magnitude faster than existing chemistry simulations,” said Georgia Tech in a press release. “The project, named OpenDAC, could accelerate climate solutions the planet desperately needs.”
Researchers at Meta’s Fundamental AI Research (FAIR) team were already looking for ways to harness their machine-learning prowess to address climate concerns. They ultimately landed on direct air capture as what they believed to be a promising technology, and immediately reached out to Georgia Tech. FAIR’s lead authors generated the database by running quantum chemistry computations on inputs provided by Georgia Tech’s team, using about 400 million CPU hours along the way, and surpassing several hundreds of times more computing than the average academic computing lab can do in a year.
Amazon.com, Inc. (NASDAQ: AMZN) through its global Amazon Web Services (AWS) cloud system subsidiary recently rolled out its new AI system called Q, which it has dubbed as “the most capable generative artificial intelligence (AI)-powered assistant for accelerating software development and leveraging companies’ internal data.”
As well, Amazon also recently launched its Custom Model Import for Bedrock tool, which CEO Andy Jassy called a “sneak big launch as it satisfies a customer request we’ve heard frequently and that nobody has yet met.” The tool allows customers to import custom models they’ve built in Amazon SageMaker into tits Amazon Bedrock platform. Doing so lets enterprises utilize AI investments they’ve already made, while also leveraging Bedrock’s capabilities to scale their models and applications.
“Customers are excited about this, and as more companies find they’re employing a mix of custom-built models along with leveraging existing LLMs,” said Jassey. “The prospect of these two linchpin services in SageMaker and Bedrock working well together is quite appealing.”
Apple Inc. (NASDAQ: AAPL), whose iPhones currently hold the Top 4 (and 5 of the Top 10) best-selling smartphone models by sales, recently reported an all-time revenue record in sales in its most recent financial results. While being seen as potentially late to the game on AI, several reports in recent weeks has suggested that Apple is not only talking to OpenAI and/or Google about powering some of its AI features, it’s also been reportedly spending “millions of dollars a day” training its own AI model, called Ajax.
Now industry experts are saying the iPhone is about to become an “AI phone”, in anticipation of Apple’s upcoming iOS 18. A key anticipated feature of iOS 18 is Apple’s own large language model (LLM), similar to the technology behind AI chatbots like ChatGPT. It’s widely speculated that this Apple-developed LLM will be integrated with Siri, enhancing the capabilities of the iPhone’s digital assistant. As indicated by Bloomberg in late April, it’s suggested that Apple’s LLM will be entirely on-device, meaning the tech will be powered inside by the iPhone’s processor, rather than in the cloud—which may be a bit less powerful and knowledgeable, but with far quicker response times.
C3.ai, Inc. (NYSE: AI), an Enterprise AI application software company, is actively working to enhance the petroleum industry in Houston, through a cooperative effort that allows oil and gas companies to share AI technology and applications with each other. This effort is meant to curb companies from withholding information from competitors, with the goal of collaboration instead.
“We’re building the applications that are, you know, monitoring every device on every offshore oil rig in real time so that they can see with 18 hours in advance before something fails and just shut it down,” said Tom Siebel, CEO of C3.ai. Siebel has explained that AI is at work in oil and gas, diagnosing issues and assisting with maintenance, giving the example of a giant like Shell uses AI to track their half a million valves around the world.
“They can see what’s going on,” said Siebel. “They can predict when a valve is going to be stuck open or closed before it happens, and if one of these valves gets stuck open or closed, things go real bad, real fast, right? And so, they’ve decided to make these applications available to Aramco, Eni, Chevron, Phillips.”
A recent report from Research and Markets predicted that the global AI in oil and gas market is expected to surge to an impressive $5.96 billion by 2028, growing at a CAGR of 13.3%.
Article Source: https://usanewsgroup.com/2024/04/26/the-currency-of-tomorrow-why-investing-in-cutting-edge-ai-recognition-tech-could-mean-big-money/
CONTACT:USA NEWS [email protected](604) 265-2873
DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. USA News Group is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Scope AI Corp. advertising and digital media from the company directly. There may be 3rd parties who may have shares Scope AI Corp., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Scope AI Corp. which were purchased as a part of a private placement. MIQ reserves the right to buy and sell, and will buy and sell shares of Scope AI Corp. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through further private placements and/or investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
View original content:https://www.prnewswire.co.uk/news-releases/economic-shifts-ahead-as-ai-integrates-deeply-into-work-and-society-fueling-4-4-trillion-growth-302140422.html
-
Artificial Intelligence6 days agoCleverTap launches Clever.AI, the AI-Driven Edge for Customer Engagement & Retention
-
Uncategorized6 days agoImproving the Developer Journey in Crafting Artificial Intelligence Applications
-
Uncategorized6 days ago
Unveiling the Complex Psychological Implications of Artificial Intelligence
-
Artificial Intelligence6 days ago5G Enterprise Market Projected to Reach $115.81 billion by 2030 – Exclusive Report by 360iResearch
-
Artificial Intelligence6 days agoBitrue expands Bitcoin Runes Offerings with GPTV Listing and Staking Options
-
Artificial Intelligence6 days agoVirtual Assistant Market Size to Grow USD 8613.5 Million by 2030 at a CAGR of 22.3% | Valuates Reports
-
Artificial Intelligence6 days agoInnodisk Introduces iCAP Air: Advancing Air Quality Management through Autonomous Decision-Making
-
Artificial Intelligence6 days agoAppian Named a Leader in the 2024 Gartner® Magic Quadrant™ for Process Mining Platforms Report
